Wednesday, November 28, 2018

Botulinum toxin shows promise in trials to reduce post-operative atrial fibrillation (POAF) in cardiac surgery patients

Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery. It can result in heart failure, stroke, and longer hospital stays, resulting in an increased cost of care. A new study reports promising results from two clinical trials using botulinum toxin (BTX) injections to suppress POAF.

from Top Health News -- ScienceDaily https://ift.tt/2rav5Fm
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Do dogs know who’s kind? Scientists put it to the test—and got a surprise

Despite our strong belief in dogs' ability to sense good from bad in people, new research shows they may not actually judge human charac...